163 related articles for article (PubMed ID: 22940579)
41. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
42. HCV-associated lymphomas.
Fiorilli M; Mecucci C; Farci P; Casato M
Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
[TBL] [Abstract][Full Text] [Related]
43. A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells.
Charles ED; Orloff MI; Dustin LB
J Immunol Methods; 2011 Jan; 363(2):210-20. PubMed ID: 20875420
[TBL] [Abstract][Full Text] [Related]
44. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase.
Willenbrock K; Jungnickel B; Hansmann ML; Küppers R
Eur J Immunol; 2005 Oct; 35(10):3002-7. PubMed ID: 16180254
[TBL] [Abstract][Full Text] [Related]
45. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation.
Timens W; Boes A; Poppema S
Eur J Immunol; 1989 Nov; 19(11):2163-6. PubMed ID: 2532141
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.
Saadoun D; Landau DA; Calabrese LH; Cacoub PP
Rheumatology (Oxford); 2007 Aug; 46(8):1234-42. PubMed ID: 17566058
[TBL] [Abstract][Full Text] [Related]
48. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process.
De Re V; De Vita S; Marzotto A; Gloghini A; Pivetta B; Gasparotto D; Cannizzaro R; Carbone A; Boiocchi M
Int J Cancer; 2000 Jul; 87(2):211-6. PubMed ID: 10861476
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus and immunoglobulin gene rearrangements: an early step in lymphomagenesis?
Santini GF; Crovatto M; Giannini F; Bortolin MT; Mazzaro C; Invernizzi F
Acta Haematol; 1998 Dec; 100(3):117-22. PubMed ID: 9858787
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer.
Ramos-Casals M; De Vita S; Tzioufas AG
Autoimmun Rev; 2005 Jan; 4(1):8-15. PubMed ID: 15652773
[TBL] [Abstract][Full Text] [Related]
51. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
52. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma.
De Vita S; De Re V; Gasparotto D; Ballarè M; Pivetta B; Ferraccioli G; Pileri S; Boiocchi M; Monteverde A
Arthritis Rheum; 2000 Jan; 43(1):94-102. PubMed ID: 10643704
[TBL] [Abstract][Full Text] [Related]
53. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.
Ferri S; Dal Pero F; Bortoletto G; Bianchi FB; Lenzi M; Alberti A; Gerotto M
J Viral Hepat; 2006 Mar; 13(3):166-76. PubMed ID: 16475992
[TBL] [Abstract][Full Text] [Related]
54. Aberrant immunoglobulin and c-myc gene rearrangements in patients with nonmalignant monoclonal cryoglobulinemia.
Perl A; Wang N; Williams JM; Hunt MJ; Rosenfeld SI; Condemi JJ; Packman CH; Abraham GN
J Immunol; 1987 Nov; 139(10):3512-20. PubMed ID: 3316385
[TBL] [Abstract][Full Text] [Related]
55. The V(H)1-69-expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21(low) phenotype.
Visentini M; Cagliuso M; Conti V; Carbonari M; Casato M; Fiorilli M
Blood; 2011 Sep; 118(12):3440-1; author reply 3442. PubMed ID: 21940829
[No Abstract] [Full Text] [Related]
56. Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis.
Quartuccio L; Fabris M; Salvin S; Isola M; Soldano F; Falleti E; Beltrami CA; De Re V; De Vita S
Rheumatology (Oxford); 2007 Nov; 46(11):1657-61. PubMed ID: 17893101
[TBL] [Abstract][Full Text] [Related]
57. Widespread B cell perturbations in HIV-1 infection afflict naive and marginal zone B cells.
Liechti T; Kadelka C; Braun DL; Kuster H; Böni J; Robbiani M; Günthard HF; Trkola A
J Exp Med; 2019 Sep; 216(9):2071-2090. PubMed ID: 31221742
[TBL] [Abstract][Full Text] [Related]
58. HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.
Sautto G; Mancini N; Solforosi L; Diotti RA; Clementi M; Burioni R
Clin Dev Immunol; 2012; 2012():705013. PubMed ID: 22690241
[TBL] [Abstract][Full Text] [Related]
59. The development of mixed cryoglobulinemia in Capillaria hepatica-infected mice is associated with the capillaria antigen-induced selective proliferation of splenic B-1a cells in response to interleukin-5 stimulation.
Aihara N; Kamiie J; Yamada M; Shirota K
Am J Pathol; 2015 Jan; 185(1):172-84. PubMed ID: 25452118
[TBL] [Abstract][Full Text] [Related]
60. CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells.
Zandvoort A; Lodewijk ME; de Boer NK; Dammers PM; Kroese FG; Timens W
Tissue Antigens; 2001 Oct; 58(4):234-42. PubMed ID: 11782274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
